Les complications de la cirrhose hépatique: varices oesophagiennes, ascite et carcinome hépato-cellulaire [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma]

Details

Serval ID
serval:BIB_B93716F4C18F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Les complications de la cirrhose hépatique: varices oesophagiennes, ascite et carcinome hépato-cellulaire [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma]
Journal
Revue médicale suisse
Author(s)
Troillet F.X., Halkic N., Froehlich F., Moradpour D., Gonvers J.J., Denys A.
ISSN
1660-9379
Publication state
Published
Issued date
2005
Volume
1
Number
3
Pages
249-50, 252-5
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review - Publication Status: ppublish
Abstract
The principal treatment for bleeding oesophageal varices is endoscopic ligation. Non-cardioselective beta-blockers are the gold-standard of primary prophylaxis. The principal treatment for ascites is a salt-free diet and diuretics, mainly spironolactone, if necessary associated with a loop diuretic. In refractory ascites, paracentesis or installation of a transjugular intrahepatic portosystemic shunt (TIPS) are two possible treatment options. Cirrhosis patients are at higher risk of developing hepato-cellular carcinoma. Surgery is only possible in a small number of cases. Percutaneous destruction techniques have nearly the same survival rate as that obtained by surgery and should be proposed to patients where surgery is not an option.
Keywords
Adrenergic beta-Antagonists, Ascites, Carcinoma, Hepatocellular, Endoscopy, Esophageal and Gastric Varices, Humans, Ligation, Liver Cirrhosis, Liver Neoplasms
Pubmed
Create date
11/04/2008 12:51
Last modification date
20/08/2019 16:27
Usage data